<DOC>
	<DOCNO>NCT00865644</DOCNO>
	<brief_summary>The purpose study determine imiquimod cream reverse growth neurofibroma . Imiquimod skin cream work stimulate body 's immune system respond tumor . Imiquimod cream approve use patient various skin lesion , include actinic keratosis , superficial basal cell carcinoma , external genital wart . Information study , well previous laboratory study , suggest imiquimod cream may help shrink neurofibromas keep grow .</brief_summary>
	<brief_title>Topical Imiquimod 5 % Cream Treatment Cutaneous Neurofibromas Adults With Neurofibromatosis 1</brief_title>
	<detailed_description>- Three participant 's tumor treat imiquimod cream one tumor ( remain tumor ) follow without treatment ( control tumor ) . - Participants give tube imiquimod cream ask apply three tumor 5 time per week , full 6 week ( Monday Friday ) . - Participants require come hospital examination Week 1 , 2 , 4 6 ( +/- 3 calendar day ) last dose imiquimod cream Weeks 9 , 12 18 ( +/- 5 calendar day . The following test procedure perform : skin test ; vital sign measurement photographs tumor . Participants ask participate optional skin biopsy Week 4 research blood test wil lbe take Day 1 .</detailed_description>
	<mesh_term>Neurofibromatoses</mesh_term>
	<mesh_term>Neurofibroma</mesh_term>
	<mesh_term>Neurofibromatosis 1</mesh_term>
	<mesh_term>Nerve Sheath Neoplasms</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Patients must diagnosis NF1 base NIH criterial two follow characteristic : six cafeaulait macule ( 1.5cm great size ) skin fold freckle axilla groin optic pathway glioma two Lisch nodule iris distinctive bony lesion dysplasia sphenoid wing long bone tibia two neurofibromas type 1 plexiform neurofibroma first degree relative NF1 Participants must least four cutaneous neurofibroma skin exam follow quality : lesion must discrete clinical exam must contact another skin tumor lesion must amenable measurement caliper minimum dimension 5mm maximum dimension 30mm lesion must locate trunk , neck , extremity ( exclude hand foot ) must locate area photograph histologic confirmation tumor type require set compatible clinical set No treatment investigation agent cutaneous neurofibroma within last 3 month 18 year age old Pregnant nursing woman Patients chemotherapy radiotherapy within 6 week prior enter study recover adverse event due agent administer 6 week earlier Patients may receive investigational agent History allergic reaction attribute compound similar chemical biologic composition imiquimod Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>imiquimod 5 % cream</keyword>
</DOC>